Jung-Kay Chiu is an intellectual property lawyer based in Toronto and the Canadian national chairman of Norton Rose Fulbright’s intellectual property group. He has over 20 years of experience practising in all areas of intellectual property law, with a focus on intellectual property acquisition, protection, and exploitation in the field of biotechnology and medical devices. He has particularly deep experience in drug delivery, stem cells, precision medicine, diagnostic biomarkers, and surgical equipment. He has worked extensively in the life sciences innovation sector with many research institutions, large corporate innovators, clusters, startups, and scaling bioscience companies, helping them formulate their innovation strategy, drive acceleration, and increase valuation. He manages multi-disciplinary teams to deliver holistic guidance to help his clients navigate the entire innovation life cycle, from IP strategy mapping and protection, to commercialization, regulatory approval, and enforcement. He is a member of the firm's management committee and sits on the board of the Ontario Bioscience Innovation Organization.
